Multifunctional Zinc Oxide Promotes Electrochemiluminescence of Porphyrin Aggregates for Ultrasensitive Detection of Copper Ion.

The design and exploration of highly efficient organic luminophores for an electrochemiluminescence (ECL) sensor is a fascinating and promising subject. Herein, we present a surfactant-assisted self-assembly of 5,10,15,20-tetrakis (4-carboxyphenyl) porphyrin (TCPP) J-aggregate as a robust organic luminophore to construct the solid-state ECL sensing platform with significantly enhanced and constantly stable signals, by using peroxydisulfate (S2O82-) as the coreactant, and l-cysteine capped zinc oxide nanoflowers (ZnO@Cys NFs) as the multifunctional energy donor and coreactant accelerator. Compared with TCPP monomer, this TCPP J-aggregate possesses a unique aggregation-induced electrochemiluminescence (AIECL) performance, which results in 5-fold enhancement in red-light ECL emission at 675 nm. The resonance energy transfer from the ZnO@Cys NFs (energy donor) to the TCPP J-aggregate (energy acceptor) substantially improves the ECL intensity and stability. ZnO@Cys NFs have also been used as a coreactant accelerator to promote the conversion of more S2O82- into SO4•-. The corresponding ECL mechanism has been investigated by UV-vis absorption spectrum, photoluminescence, ECL, and density functional theory. Since l-cysteine on ZnO@Cys NFs can efficiently realize bidentate chelation with Cu2+, the proposed ECL sensor shows a highly selective and sensitive quenching effect for the detection of Cu2+ with a wide linear range from 1.0 pmol·L-1 to 500 nmol·L-1 and a detection limit of 0.33 pmol·L-1, paving a bright research direction for the development of TCPP aggregates in ECL field.

Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism.

Reduction of lipid absorption has been recognized as an attractive approach for the discovery of new drugs to treat obesity and overweight. The leave extract of Ginkgo biloba has been widely used for the treatment of metabolic diseases (such as hyperlipidemia) in both eastern and western countries, but the bioactive compounds in Ginkgo biloba and the underlying mechanism have not been fully characterized. This study aimed to investigate the inhibition potentials and mechanism of major biflavones from G. biloba on pancreatic lipase (PL), a key target regulating lipid absorption. The results clearly demonstrated that all tested biflavones in G. biloba including isoginkgetin, bilobetin, ginkgetin and sciadopitysin, displayed strong to moderate inhibitory effects on PL with the IC50 values ranging from 2.90 µM to 12.78 µM. Further investigations on both inhibition kinetic analyses and docking simulations demonstrated that isoginkgetin, bilobetin and ginkgetin were potent PL inhibitors (Ki < 2.5 µM), which could create strong interactions with the catalytic triad of PL via hydrogen bonding. These findings provided a new powerful evidence for explaining the hypolipidemic effects of G. biloba, while these newly identified PL inhibitors from G. biloba could serve as lead compounds for the development of biflavonoid-type PL inhibitors.

Characterization and structure-activity relationship studies of flavonoids as inhibitors against human carboxylesterase 2.

Human carboxylesterases (hCEs) are key enzymes from the serine hydrolase superfamily. Among all identified hCEs, human carboxylesterase 2 (hCE2) plays crucial roles in the metabolic activation of ester drugs including irinotecan and flutamide. Selective and potent hCE2 inhibitors could be used to alleviate the toxicity induced by hCE2-substrate drugs. In this study, more than fifty flavonoids were collected to assay their inhibitory effects against hCE2 using a fluorescence-based method. The results demonstrated that C3 and C6 hydroxy groups were essential for hCE2 inhibition, while O-glycosylation or C-glycosylation would lead to the loss of hCE2 inhibition. Among all tested flavonoids, 5,6-dihydroxyflavone displayed the most potent inhibitory effect against hCE2 with the IC50 value of 3.50 µM. The inhibition mechanism of 5,6-dihydroxyflavone was further investigated by both experimental and docking simulations. All these findings are very helpful for the medicinal chemists to design and develop more potent and highly selective flavonoid-type hCE2 inhibitors.